Nu Skin Enterprises

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, Grow Tech, and Rhyz Other. The first seven segments represent the Nu Skin geographic operations. The last three segments deal with Rhyz investments. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nu Skin Enterprises reports $2.23B revenue for 2022, focuses on innovation and social commerce

Nu Skin Enterprises navigated challenges in 2022, focusing on innovation and social commerce to drive revenue growth. The company aims to overcome challenges in 2023 and achieve Nu Vision 2025 goals through strategic initiatives. Nu Skin's emphasis on enhancing the iO experience and optimizing expenses positions it for sustainable value to investors.

Nu Skin Enterprises meets Q1 expectations, eyes growth in Asia

Nu Skin's Q1 performance in line with expectations, with notable success in key markets like South Korea and Mainland China.
Challenges persist in certain regions due to macroeconomic factors, necessitating strategic adjustments for sustained growth.
Opportunities lie in expanding TRMe program, leveraging digital initiatives, and driving operational improvements for long-term value creation.

Nu Skin reports robust Q2 earnings, eyes growth through acquisitions

Nu Skin Enterprises delivered strong Q2 results driven by Mainland China growth, with revenue of $500.3 million and EPS of $0.54. The company faces challenges in other markets due to macro-related pressures.
Strategic acquisitions of BeautyBio and LifeDNA aim to enhance Nu Skin's core business through personalization and technology. The company's focus on innovation and market trends presents growth opportunities.
With a clear strategic direction, Nu Skin is poised to navigate challenges, capitalize on opportunities, and drive continued growth in the beauty and wellness industry.

Nu Skin reports Q3 revenue of $499M, adjusts 2023 guidance

Nu Skin adjusts 2023 guidance, expecting revenue of $1.92B to $1.96B and EPS of negative $0.10 to $0.05. The company is streamlining expenses and maximizing cash flow.

Nu Skin surpasses Q4 revenue targets, eyes growth opportunities

Nu Skin Enterprises delivered strong Q4 results, exceeding revenue guidance and showcasing a focus on innovation and strategic growth initiatives.
Despite challenges in certain regions, the company demonstrated resilience and stability in key markets, laying the groundwork for future expansion and market penetration.
By rebalancing dividends for growth investments and prioritizing reinvestment in the business, Nu Skin is poised to capitalize on opportunities for market diversification and sustainable growth.
With a clear roadmap for 2024, including product launches, market entries, and capital reallocation strategies, Nu Skin is well-positioned to drive performance and enhance shareholder value.

Nu Skin Enterprises reports robust Q1 earnings, eyes global expansion

Nu Skin Enterprises showcased resilience in revenue and earnings, driven by strong performance in core and new business segments.
While facing challenges from macroeconomic factors, the company is strategically focused on innovation, cost efficiency, and market expansion.
Opportunities lie in product diversification, market entries, and sustainability efforts, positioning Nu Skin for future growth and market leadership.

Nu Skin surpasses Q2 revenue targets, eyes growth amid challenges

Nu Skin Enterprises delivered strong Q2 performance, exceeding revenue guidance and showcasing financial discipline. Despite challenges in China and FX pressures, the company remains focused on innovation and growth. Strategic investments in new products, markets, and brand awareness position Nu Skin for future success. Revised guidance reflects adaptability to market conditions and commitment to long-term vision.

Nu Skin Enterprises meets Q3 guidance, eyes India expansion

Nu Skin's Q3 performance reflects a balanced approach to addressing challenges and leveraging strengths.
Strategic initiatives to drive growth, optimize operations, and expand into new markets are key focus areas.
Despite market pressures, Nu Skin's focus on innovation and efficiency bodes well for future growth.
Overall, Nu Skin's financials and strategic direction indicate a resilient and forward-thinking company.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of beauty and wellness solutions. It operates through the following segments: Mainland China, Americas, South Korea, Southeast Asia/Pacific, EMEA, Japan, Hong Kong/Taiwan, Nu Skin Other, Manufacturing, and Rhyz Other. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.

Apple

Compania Cervecerias Unidas

Greif

These consumer staples stocks offer dividend income and trade at lowered valuations for increased profits in the future.

4 Consumer Staples Stocks for Both Income and Growth

Nu Skin (NUS) focuses on capturing greater market share through sales leaders. However, the company is battling currency headwinds.

Nu Skin (NUS) Up 6% in a Month: Can It Maintain Momentum?

Enphase Energy

Royal Caribbean Cruises

Earnings helped some stocks outperform as the latest Federal Reserve decision kept markets in check.

Why Royal Caribbean Cruises, Enphase Energy, and Nu Skin Enterprises Jumped Today

Increases in revenue and customer base have the company sitting pretty.

Strong Q1 Sends Shares of Nu Skin Enterprises Over 27% Higher Wednesday Morning

Estee Lauder

Nu Skin stock exploded after the firm handily beat earnings estimates. Estee Lauder stock also rose after it bested analyst expectations.

Nu Skin In The Game: Estee Lauder, Rival Deliver These Surprises

The performance can be attributed to Nu Skin's (NUS) technology and business expansion initiatives as well as customer acquisition and retention program.

Nu Skin (NUS) Beats on Q1 Earnings & Revenues, Q2 View Soft

NU Skin Enterprises, Inc. (NUS) CEO Ritch Wood on Q1 2019 Results - Earnings Call Transcript

Nu Skin's (NUS) is likely to benefit from effective marketing programs, gains from social media and a solid sales leaders' network. These factors are set to drive customer count in Q1.

Here's What You Must Note Ahead of Nu Skin (NUS) Q1 Earnings

Nu Skin gains from an expanding customer base and prudent product launches. However, persistent decline in gross margin is a concern.

Nu Skin Boasts Customer Growth, Faces Weak Gross Margin

Investors got queasy after China ramped up scrutiny over sales of wellness products.

Why Nu Skin Enterpises Stock Dropped 20% in March

Multi-level marketing company Nu Skin Enterprises, Inc. has been embroiled in a recent controversy surrounding a customer death who reportedly relied solely on the company's health products to treat fever.

Stifel Downgrades Nu Skin To Sell Amid Chinese Clampdown On Direct Selling

Shares of Nu Skin Enterprises Inc. sank 2.6% toward a fresh 2-year low in premarket trade Monday.

Nu Skin's stock extends tumble toward 2-year low after Stifel analyst turns bearish

News for Nu Skin Enterprises Stock (NUS)